Hypnosis During a Heart Ultrasound Through the Throat
Tests conversational hypnosis during a throat heart ultrasound in adults with heart disease.
Plain-language title generated from the registry record
Registry title: Evaluation of the Benefits of Hypnosis During Transoesophageal Echocardiography
Key facts
- Where
- Paris, FranceSee the site
Where in France
- Hôpital Paris Saint JosephParis, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fondation Hôpital Saint-Joseph
- Trial code
- NCT07512830
- Record updated
- 6 April 2026
- Original description
Transoesophageal echocardiography (TOE) is a routine cardiology examination that is performed in most cases under local anaesthesia and is recommended for many indications.The objective of our study will be to evaluate the expected beneficial effect of using conversational hypnosis and hypnosis during a transoesophageal ultrasound examination performed directly in the examination room by the cardiologist conducting the examination.Read full original descriptionShow less
Evaluation of the Benefits of Hypnosis During Transoesophageal Echocardiography
Transoesophageal echocardiography (TOE) is a routine cardiology examination that is performed in most cases under local anaesthesia and is recommended for many indications.The objective of our study will be to evaluate the expected beneficial effect of using conversational hypnosis and hypnosis during a transoesophageal ultrasound examination performed directly in the examination room by the cardiologist conducting the examination.
Inclusion: Patient aged ≥ 18 years old; Patient requiring a transoesophageal ultrasound scan under local anaesthetic; Patient affiliated to a health insurance scheme; French-speaking patient; Patient who has given their free, informed and express verbal consent.
Exclusion: Patient with a contraindication to transoesophageal ultrasound (significant radiation exposure to the chest, oesophageal pathology with risk of bleeding); Patients with known schizophrenia or known psychiatric illness (documented in medical records); Patients with known dementia or known cognitive impairment (documented in medical records); Patients already included in an interventional research protocol; Patients under guardianship or curatorship; Patients deprived of their liberty; Patients under judicial protection; Pregnant or breastfeeding patients.